Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Type”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03119259
What this trial is testing

Technology Intervention to Support Caregiving for Alzheimer's Disease (I-CARE)

Who this might be right for
Dementia, Alzheimer Type
Indiana University 53
Testing effectiveness (Phase 2)Looking for participantsNCT06362707
What this trial is testing

Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)

Who this might be right for
Cognitive Decline, MildAlzheimer Disease
Helse Stavanger HF 200
Very early researchActive Not RecruitingNCT05469009
What this trial is testing

Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease 1
Ali Rezai 15
Not applicableLooking for participantsNCT07482072
What this trial is testing

Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study

Who this might be right for
Alzheimer Dementia (AD)Diabete Type 2
Rigshospitalet, Denmark 60
Testing effectiveness (Phase 2)Study completedNCT06745583
What this trial is testing

Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Who this might be right for
Mild, Moderate, or Severe Alzheimer's Disease
Elixiron Immunotherapeutics Inc. 7
Testing effectiveness (Phase 2)Study completedNCT01928420
What this trial is testing

A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Humanetics Corporation 30
Large-scale testing (Phase 3)Study completedNCT01922258
What this trial is testing

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 270
Not applicableEnded earlyNCT02020356
What this trial is testing

Music Therapy in Alzheimer's Disease

Who this might be right for
Alzheimer's Type Dementia
University Hospital, Toulouse 35
Large-scale testing (Phase 3)Study completedNCT00103649
What this trial is testing

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Sanofi 1,306
Testing effectiveness (Phase 2)Study completedNCT01273272
What this trial is testing

Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers

Who this might be right for
Alzheimer Disease
University of Zurich 50
Large-scale testing (Phase 3)Looking for participantsNCT07251023
What this trial is testing

Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia

Who this might be right for
Alzheimer Type Dementia
Bigespas LTD 450
Large-scale testing (Phase 3)Study completedNCT05557409
What this trial is testing

Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation
Axsome Therapeutics, Inc. 408
Large-scale testing (Phase 3)Ended earlyNCT00322036
What this trial is testing

Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

Who this might be right for
Alzheimer DiseaseDementia
Myrexis Inc. 800
Large-scale testing (Phase 3)Study completedNCT03724942
What this trial is testing

Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Co., Ltd. 164
Not applicableStudy completedNCT03384043
What this trial is testing

Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseCognitive Impairment, MildDementia, Mild
Baylor University 52
Large-scale testing (Phase 3)Active Not RecruitingNCT06125951
What this trial is testing

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

Who this might be right for
Dementia ModerateDementia, MildAlzheimer Disease
Actinogen Medical 247
Not applicableLooking for participantsNCT06965062
What this trial is testing

Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)

Who this might be right for
Alzheimer DiseaseDementia Alzheimer TypeDementia Alzheimer's Type+2 more
Vincent Tay Khwee Soon 10
Not applicableNot Yet RecruitingNCT07521722
What this trial is testing

DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community

Who this might be right for
Alzheimer DiseaseCognitive Dysfunction, Cognitive DisorderDementia+1 more
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation 250
Not applicableStudy completedNCT04742465
What this trial is testing

ARIADE : Augmented Reality for Improving Autonomy in Dementia

Who this might be right for
Alzheimer or Mild Cognitive Impairment
Rennes University Hospital 19
Testing effectiveness (Phase 2)Study completedNCT02727699
What this trial is testing

A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)

Who this might be right for
Dementia, Alzheimer Type
Actinogen Medical 185
Next Page